Gianotti A
Responsabile Laboratorio di Analisi Pastorino, USL 3 Genovese, Genova.
Clin Ter. 1994 Oct;145(10):283-5.
Twenty patients with high serum levels of Lp(a) were randomly treated with 900 mg/day telmestein or placebo. We found, in those treated with telmestein, a significant decrease of lipoprotein (a) serum levels (p < 0.05).
20名血清脂蛋白(a)[Lp(a)]水平较高的患者被随机给予替尔泊肽900毫克/天或安慰剂治疗。我们发现,接受替尔泊肽治疗的患者血清脂蛋白(a)水平显著降低(p<0.05)。